Who Paid My Doc
Justin Ogbonna
Podiatrist, Foot Surgery Boston, MA Doctor of Podiatric Medicine
NPI 1952626483 CMS profile 269997
732 Harrison Avenue, Preston 5Th Floor, Boston, MA 02118
General payments
$3,948
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Justin Ogbonna of Boston, MA is reported in the CMS Open Payments database as having received $3,948 across 31 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 83rd percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $601 | 5 | |
| 2024 | General | $1,037 | 10 | |
| 2023 | General | $263 | 4 | |
| 2022 | General | $293 | 5 | |
| 2021 | General | $1,215 | 2 | |
| 2020 | General | $189 | 2 | |
| 2019 | General | $351 | 3 |
Beside peers
- Justin Ogbonna
- Podiatrist, Foot Surgery median
- Middle half of Podiatrist, Foot Surgery
- National median
In program year 2025, general payments to Justin Ogbonna were reported at $601. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.
Show as a table
| Year | Justin Ogbonna | Podiatrist, Foot Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $351 | $167 | $67–$484 | $163 |
| 2020 | $189 | $114 | $40–$323 | $114 |
| 2021 | $1,215 | $171 | $57–$502 | $132 |
| 2022 | $293 | $196 | $66–$556 | $149 |
| 2023 | $263 | $187 | $78–$466 | $160 |
| 2024 | $1,037 | $190 | $78–$557 | $164 |
| 2025 | $601 | $180 | $70–$569 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 10 drugsPart D claims
438
Drug cost
$10,583
Branded share of claims
7.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 221 | $5,952 | |
| Clotrimazole | Generic | 61 | $1,418 | |
| Terbinafine Hcl | Generic | 26 | $682 | |
| Econazole Nitrate | Generic | 12 | $577 | |
| Diclofenac Sodium | Generic | 32 | $547 | |
| Ciclopirox | Generic | 11 | $542 | |
| Ammonium Lactate | Generic | 29 | $481 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 16 | $164 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 15 | $135 | |
| Oxycodone Hcl | Generic | 15 | $85 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 45 billing codesPaid by Medicare
$34,216
Medicare patients
297
Services billed
748
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 71% | |
| Chronic kidney disease | 37% | |
| Arthritis | 35% | |
| Ischemic heart disease | 26% | |
| Depression | 25% | |
| Heart failure | 22% | |
| COPD | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
31 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Podiatrist, Foot Surgery in Massachusetts
Adam Landsman
Podiatrist, Foot Surgery · Boston, MA
Mark Rose
Podiatrist, Foot Surgery · Natick, MA
Jamey Allen
Podiatrist, Foot Surgery · Woburn, MA
Ewald Mendeszoon
Podiatrist, Foot Surgery · West Roxbury, MA
Christopher Locke
Podiatrist, Foot Surgery · Boston, MA
Jurgen Fernandez
Podiatrist, Foot Surgery · Lynn, MA
Related records
Podiatrist, Foot Surgery in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Podiatrist, Foot Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.